## BRO: Brown & Brown, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -0.5% below STRENGTH zone (4.0-10.0%); PEG 4.41 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($77.02)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. A Look At Brown & Brown (BRO) Valuation After Court-Imposed Limits On Rival Poaching**
- Source: Simply Wall Street | 20260106T012846 | Somewhat-Bullish | Relevance: 100%
- Brown & Brown (BRO) recently secured a temporary restraining order against a rival and former employees, yet its stock has seen a decline in short-term returns despite stronger long-term momentum. Analysts have a consensus price target of $109.917, valuing it at approximately $92.86 per share, suggesting it might be undervalued given its current trading price of $77.62. Investors are encouraged to consider potential risks to this valuation, such as weaker revenue growth or pressure on profit margins.

**2. Hentges Sheridan joins Brown & Brown as chief captives compliance counsel**
- Source: Captive Insurance Times | 20260105T210757 | Somewhat-Bullish | Relevance: 100%
- Dana Hentges Sheridan has been appointed chief captives compliance counsel for Accession Risk Management Group and Brown & Brown, following Brown & Brown's acquisition of Accession in August 2025. In this new role, she will oversee compliance for Accession, which includes Risk Strategies and One80 Intermediaries. Hentges Sheridan brings 30 years of insurance experience, including previous roles as general counsel for Accession's captives division and at Acrisure.

**3. Court grants Brown & Brown TRO against Howden**
- Source: Insurance Business | 20260105T155939 | Somewhat-Bullish | Relevance: 100%
- A Massachusetts court has issued a temporary restraining order (TRO) against Howden US Services LLC in a lawsuit filed by Brown & Brown Inc., alleging a nationwide employee poaching scheme. The lawsuit claims that approximately 200 Brown & Brown employees have joined Howden since December 18. The TRO prohibits Howden from soliciting Brown & Brown employees and restricts former employees from soliciting clients for whom they provided services in the past 24 months, while the case proceeds towards an evidentiary hearing.

**4. Brown and Brown secures court win against Howden**
- Source: Insurance Times | 20260105T091000 | Bullish | Relevance: 100%
- Brown and Brown and Aon have secured injunctions against Howden in separate US court cases. These injunctions restrict Howden's ability to hire employees, solicit clients, and use confidential information following mass departures of brokers to Howden, marking significant wins for the employers. The Suffolk County Superior Court issued a temporary restraining order against Howden US Services, and a preliminary injunction was granted in the Southern District of New York against Howden in a case brought by Aon.

**5. Hentges Sheridan joins Brown & Brown as chief captives compliance counsel**
- Source: Captive Insurance Times | 20260105T204905 | Somewhat-Bullish | Relevance: 100%
- Dana Hentges Sheridan has been appointed chief captives compliance counsel for Accession Risk Management Group and Brown & Brown, following Brown & Brownâ€™s acquisition of Accession in August 2025. In this new role, she will oversee compliance for Accession, which includes Risk Strategies and One80 Intermediaries. Hentges Sheridan brings 30 years of experience in the insurance field to her new position, previously serving as general counsel for Accession's captives division and as a founder of CIRA Solutions, LLC.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-06 | Keefe, Bruyette | $80 | $79 | +1% |
| 2025-12-23 | BMO Capital | $88 | $90 | -2% |
| 2025-12-18 | JP Morgan | $91 | $0 | 0% |
| 2025-12-16 | Mizuho | $89 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-06 | Keefe, Bruyette | main | Underperform |
| 2025-12-23 | BMO Capital | down | Market Perform |
| 2025-12-18 | JP Morgan | init | Neutral |
| 2025-12-16 | Mizuho | init | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 3 ($0.00M) |
| Sells | 5 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 10.9% (+4.8%)
- Blackrock Inc.: 6.1% (+2.2%)
- Capital World Invest: 5.1% (+81.1%)
- Principal Financial : 4.5% (+13.4%)
- State Street Corpora: 3.8% (+5.3%)

### Key Risks

1. Valuation stretched: PEG 4.4x requires aggressive growth execution.
2. Long-term trend broken: trading 18.2% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 4.41 signals overvaluation risk, limited margin of safety. Quality metrics strong (margin 19%). Revenue growth strong at 23% YoY. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $27.4B |
| Beta | 0.81 |
| 52W Range | $76.17 - $125.68 |
| Short Interest | 4.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.41 |
| Forward P/E | 17.2 |
| Current P/E | 18.9 |
| YoY Growth | 9.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 weakening modestly (-0.6% over 5 days). Below STRENGTH zone by 4.5pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.1%) - potential reversal signal. Below SMA200 (0.82x), long-term trend not supportive. RSI neutral at 50. OFD pattern: +MUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.51% (CS: 33) | Neutral |
| RSI_14 | 49.8 | Neutral |
| MACD Histogram | 0.02 | Bullish |
| vs SMA20 | 1.003x | Above |
| vs SMA50 | 1.002x | Above |
| vs SMA200 | 0.818x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $80.26
- **Stop Loss:** $77.02 (4.0% risk)
- **Target:** $83.50 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 407
- **Position Value:** $32,665.82
- **Portfolio %:** 32.67%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

**Next:** 2026-01-26 (Est: $0.90)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.93 | $1.05 | +12.9% |
| 2025Q2 | $0.99 | $1.03 | +4.6% |
| 2025Q1 | $1.30 | $1.29 | -0.5% |
| 2024Q4 | $0.77 | $0.86 | +12.1% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_20*